140 related articles for article (PubMed ID: 25743010)
1. The CYVADIC regimen as a combination chemotherapy treatment option for advanced soft tissue sarcomas originating from the non-extremities.
Nakano K; Motoi N; Takahashi S
Intern Med; 2015; 54(2):187-93. PubMed ID: 25743010
[TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced soft tissue sarcomas with a modified CYVADIC protocol.
Pfeffer MR; Sulkes A; Biran S
Oncology; 1984; 41(5):308-13. PubMed ID: 6548004
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up.
Odunsi K; Moneke V; Tammela J; Ghamande S; Seago P; Driscoll D; Marchetti D; Baker T; Lele S
Int J Gynecol Cancer; 2004; 14(4):659-64. PubMed ID: 15304162
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Santoro A; Tursz T; Mouridsen H; Verweij J; Steward W; Somers R; Buesa J; Casali P; Spooner D; Rankin E
J Clin Oncol; 1995 Jul; 13(7):1537-45. PubMed ID: 7602342
[TBL] [Abstract][Full Text] [Related]
5. Analysis of a series of sixty soft tissue sarcomas in adults treated with a cyclophosphamide-vincristine-adriamycin-dacarbazine (CYVADIC) combination.
Bui NB; Chauvergne J; Hocke C; Durand M; Brunet R; Coindre JM
Cancer Chemother Pharmacol; 1985; 15(1):82-5. PubMed ID: 3891123
[TBL] [Abstract][Full Text] [Related]
6. Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trial.
Hempling RE; Piver MS; Baker TR
Am J Clin Oncol; 1995 Aug; 18(4):282-6. PubMed ID: 7625366
[TBL] [Abstract][Full Text] [Related]
7. Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma Group.
Pinedo HM; Bramwell VH; Mouridsen HT; Somers R; Vendrik CP; Santoro A; Buesa J; Wagener T; van Oosterom AT; van Unnik JA
Cancer; 1984 May; 53(9):1825-32. PubMed ID: 6367947
[TBL] [Abstract][Full Text] [Related]
8. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of soft tissue sarcoma--a clinical evaluation of treatment over ten years.
Wall N; Starkhammar H
Acta Oncol; 2003; 42(1):55-61. PubMed ID: 12665332
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Bramwell V; Rouesse J; Steward W; Santoro A; Schraffordt-Koops H; Buesa J; Ruka W; Priario J; Wagener T; Burgers M
J Clin Oncol; 1994 Jun; 12(6):1137-49. PubMed ID: 8201375
[TBL] [Abstract][Full Text] [Related]
11. [Toxicity of the CYVADIC modification in patients with soft tissue sarcomas or malignant mesotheliomas].
Sauer H; Kremer G; Wilmanns W
Onkologie; 1987 Oct; 10(5):294-300. PubMed ID: 3317170
[TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.
Yap BS; Baker LH; Sinkovics JG; Rivkin SE; Bottomley R; Thigpen T; Burgess MA; Benjamin RS; Bodey GP
Cancer Treat Rep; 1980 Jan; 64(1):93-8. PubMed ID: 7379060
[TBL] [Abstract][Full Text] [Related]
13. Ifosfamide, vincristine, doxorubicin and dacarbazine in adult patients with advanced soft-tissue sarcoma.
Wiklund TA; Blomqvist CP; Virolainen M; Elomaa I
Cancer Chemother Pharmacol; 1992; 30(2):100-4. PubMed ID: 1600589
[TBL] [Abstract][Full Text] [Related]
14. [Palliative chemotherapy of adult soft tissue sarcomas with an association of cyclophosphamide-vincristine-adriamycine-dacarbazine (CYVADIC) (author's transl)].
Bui B; Chauvergne J; Durand M; Brunet R
Bull Cancer; 1981; 68(1):1-5. PubMed ID: 7225604
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy of advanced sarcomas in adults with "CYOMAD" (S7).
Lynch G; Magill GB; Sordillo P; Golbey RB
Cancer; 1982 Nov; 50(9):1724-7. PubMed ID: 6981452
[TBL] [Abstract][Full Text] [Related]
16. Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine: a single-center experience.
Deutschbein T; Matuszczyk A; Moeller LC; Unger N; Yuece A; Lahner H; Mann K; Petersenn S
Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):540-3. PubMed ID: 21667440
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin-dacarbazine combination chemotherapy for the treatment of advanced soft tissue sarcoma of the limbs.
Zong XY; Yu Y; Yang HJ
J Exp Clin Cancer Res; 2009 Aug; 28(1):119. PubMed ID: 19709417
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide, vincristine, adriamycin, and dimethyl-triazeno imidazole carboxamide (CYVADIC) for sarcomas of the female genital tract.
Piver MS; DeEulis TG; Lele SB; Barlow JJ
Gynecol Oncol; 1982 Dec; 14(3):319-23. PubMed ID: 6897542
[No Abstract] [Full Text] [Related]
19. Retrospective analysis of the CYVADIC regimen in advanced soft tissue sarcomas.
Frustaci S; Lo Re G; Crivellari D; De Paoli A; Galligioni E; Franchin G; Tumolo S; Monfardini S
Tumori; 1989 Apr; 75(2):152-5. PubMed ID: 2741222
[TBL] [Abstract][Full Text] [Related]
20. [Pilot study of an alternative CYVADIC + CBDCA protocol for adult soft tissue sarcoma as adjuvant chemotherapy].
Matsumoto S; Kawaguchi N; Manabe J; Matsushita Y; Tanizawa T
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1571-4. PubMed ID: 12355942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]